Proteomic analyses of ascites from SPC patients have validated the glycolytic shift in these cancers, as evidenced by the increased expression of GLUT1 and the glycolytic enzyme, LDH, in peritoneal metastases of ovarian cancer [50]. The gene discussed is SLC2A1; the disease is cancer.